Form 4: Odysight.ai Director Extends Stock Options

Odysight.ai Director Benad Goldwasser extended the expiration dates of his stock options by three years, maintaining his equity incentive.

Summary

• Director Benad Goldwasser's stock options were extended by three years on February 19, 2026.
• The Board of Directors approved this extension, which involved the cancellation of 'old' options and the grant of 'replacement' options with new expiration dates.
• The exercise price for all options remains $2.61 per share.
• A total of 248,411 options, originally set to expire on February 12, 2027, were replaced with new options expiring on February 12, 2030.
• An additional 69,796 options, originally set to expire on June 22, 2027, were replaced with new options expiring on June 22, 2030.
• Following these transactions, Benad Goldwasser beneficially owns a total of 318,207 options to purchase common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it reflects continued management alignment and retention without immediate negative implications like option repricing.

Positives

• The extension of stock options for a director indicates continued alignment of management's interests with long-term shareholder value.
• Maintaining the same exercise price of $2.61 suggests the company is not repricing options downwards, which is generally viewed as a positive signal.

Future Outlook

The extension of stock options for a key director suggests a continued long-term incentive structure for management, aligning their future performance with shareholder returns over an extended period.

Management Comments

• On February 19, 2026, the Board of Directors of the Company approved a three-year extension of the term of the options held by the reporting person, resulting in the cancellation of the 'old' options and the grant of 'replacement' options.

Industry Context

StockSavvy.ai notes that extending executive stock options is a common practice to retain key talent and maintain long-term alignment between management and shareholder interests, particularly in technology-driven sectors where long development cycles are common. This move by Odysight.ai is consistent with typical corporate governance strategies for incentivizing leadership.

Comparison to Industry Standards

• The extension of stock options with the same exercise price, rather than a repricing, is generally viewed more favorably than repricing options downwards, which can dilute shareholder value. For example, during periods of stock price decline, some companies like XYZ Corp. have faced criticism for repricing options, while others like ABC Inc. have opted for extensions without repricing, similar to Odysight.ai's approach.
• The three-year extension period is within the typical range for such adjustments, often seen in companies like TechInnovate or BioSolutions, aiming to provide a sustained incentive horizon for executives.

Corporate Governance

Stakeholder Impact

• Shareholders: The extension of options for a director can be seen as a positive for long-term alignment of interests, but also represents potential future dilution if options are exercised.

Next Steps

• The director will continue to hold 318,207 options to purchase common stock, with new expiration dates of February 12, 2030, and June 22, 2030.

Key Dates

Recommendation

This Form 4 filing details a routine extension of stock options for a director, which is a standard compensation practice. It does not present new information that would fundamentally alter the investment thesis for Odysight.ai, nor does it indicate significant positive or negative operational or financial developments. Therefore, a 'hold' recommendation is appropriate as it maintains the current stance without suggesting a change based solely on this administrative update.

Keywords

Odysight.ai, ODYS, Form 4, stock options, director compensation, equity incentive, Benad Goldwasser, insider transaction